Provided by Tiger Trade Technology Pte. Ltd.

Vor Biopharma Inc.

19.08
+0.75004.09%
Pre-market: 18.74-0.3427-1.80%07:22 EDT
Volume:1.07M
Turnover:20.64M
Market Cap:1.13B
PE:1.66
High:19.81
Open:18.54
Low:18.38
Close:18.33
52wk High:49.64
52wk Low:6.50
Shares:59.16M
Float Shares:37.23M
Volume Ratio:0.69
T/O Rate:2.87%
Dividend:- -
Dividend Rate:- -
EPS(TTM):11.53
EPS(LYR):-70.5015
ROE:-125.43%
ROA:-21.37%
PB:-5.64
PE(LYR):-0.27

Loading ...

Vor Bio says China NMPA approves telitacicept for Sjögren’s disease

Reuters
·
Jun 08

Vor Bio says telitacicept wins China conditional approval for IgA nephropathy

Reuters
·
Jun 08

Telitacicept Receives Nmpa Conditional Approval for the Treatment of Iga Nephropathy in China

THOMSON REUTERS
·
Jun 08

Vor Biopharma’s Phase 3 Sjögren’s Trial Puts Telitacicept on Investors’ Radar

TIPRANKS
·
Jun 05

Vor Bio grants 61,050 stock options, 12,900 RSUs to new hires under inducement plan

Reuters
·
Jun 02

Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Jun 02

Vor Biopharma Price Target Maintained With a $31.00/Share by HC Wainwright & Co.

Dow Jones
·
May 19

Vor Bio price target raised to $18 from $15 at Wedbush

TIPRANKS
·
May 15

Vor Biopharma Is Maintained at Neutral by Wedbush

Dow Jones
·
May 14

Wedbush Adjusts Price Target on Vor Biopharma to $18 From $15, Maintains Neutral Rating

MT Newswires Live
·
May 14

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Staar Surgical (STAA), Halozyme (HALO) and Vor Biopharma (VOR)

TIPRANKS
·
May 14

Vor Biopharma Q1 Adj. EPS $(0.73) Beats $(0.78) Estimate

Benzinga Earnings
·
May 13

Earnings Flash (VOR) Vor Biopharma Posts Q1 Net Loss $5.11 a Share, vs. FactSet Est of $0.78 Loss

MT Newswires Live
·
May 13

Vor Biopharma Q1 net loss widens

Reuters
·
May 13

Vor Bio Reports First Quarter 2026 Financial Results and Provides Corporate Update

THOMSON REUTERS
·
May 13

Vor Biopharma Q1 Net Income USD -219.6 Million VS. Ibes Estimate USD -32.8 Million

THOMSON REUTERS
·
May 13

Hisense Mulakan Kempen FIFA World Cup 2026™, Dekatkan Peminat Dengan "Menginovasi Kehidupan Lebih Cerah"

prnewswire
·
May 11

Hisense เปิดตัวแคมเปญ FIFA World Cup 2026™ พาแฟนบอลใกล้ชิดเกมการแข่งขันมากขึ้นผ่านแนวคิด "Innovating a Brighter Life"

prnewswire
·
May 11

Vor Biopharma Advances Phase 3 Telitacicept Trial in Myasthenia Gravis, Keeping Investor Focus High

TIPRANKS
·
May 09

Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
May 05